+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Diabetes Devices - Global Market Trajectory & Analytics

  • PDF Icon

    Report

  • 180 Pages
  • September 2020
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5141202
Global Diabetes Devices Market to Reach $36.7 Billion by 2027

Amid the COVID-19 crisis, the global market for Diabetes Devices estimated at US$24.7 Billion in the year 2020, is projected to reach a revised size of US$36.7 Billion by 2027, growing at a CAGR of 5.8% over the period 2020-2027. Monitoring and Diagnostic Devices, one of the segments analyzed in the report, is projected to record 5.8% CAGR and reach US$26.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Insulin Delivery Devices segment is readjusted to a revised 6% CAGR for the next 7-year period.





The U. S. Market is Estimated at $6.7 Billion, While China is Forecast to Grow at 8.9% CAGR

The Diabetes Devices market in the U. S. is estimated at US$6.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$7.8 Billion by the year 2027 trailing a CAGR of 8.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 5.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR. We bring years of research experience to this 6th edition of our report. The 180-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Medtronic PLC
  • Novo Nordisk A/S
  • Sanofi SA
Frequently Asked Questions about the Global Market for Diabetes Devices

What is the estimated value of the Global Market for Diabetes Devices?

The Global Market for Diabetes Devices was estimated to be valued at $24.7 Billion in 2020.

What is the growth rate of the Global Market for Diabetes Devices?

The growth rate of the Global Market for Diabetes Devices is 5.8%, with an estimated value of $36.7 Billion by 2027.

What is the forecasted size of the Global Market for Diabetes Devices?

The Global Market for Diabetes Devices is estimated to be worth $36.7 Billion by 2027.

Table of Contents

I. INTRODUCTION, METHODOLOGY & REPORT SCOPEII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Global Competitor Market Shares
  • Diabetes Devices Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Current & Future Analysis for Diabetes Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
  • TABLE 2: World Historic Review for Diabetes Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 3: World 15-Year Perspective for Diabetes Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
  • TABLE 4: World Current & Future Analysis for Monitoring and Diagnostic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
  • TABLE 5: World Historic Review for Monitoring and Diagnostic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 6: World 15-Year Perspective for Monitoring and Diagnostic Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
  • TABLE 7: World Current & Future Analysis for Insulin Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
  • TABLE 8: World Historic Review for Insulin Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 9: World 15-Year Perspective for Insulin Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSISGEOGRAPHIC MARKET ANALYSIS
UNITED STATES
  • Market Facts & Figures
  • US Diabetes Devices Market Share (in %) by Company: 2019 & 2025
  • Market Analytics
  • TABLE 10: USA Current & Future Analysis for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 11: USA Historic Review for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 12: USA 15-Year Perspective for Diabetes Devices by Segment - Percentage Breakdown of Value Sales for Monitoring and Diagnostic Devices and Insulin Delivery Devices for the Years 2012, 2020 & 2027

CANADA
  • TABLE 13: Canada Current & Future Analysis for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 14: Canada Historic Review for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 15: Canada 15-Year Perspective for Diabetes Devices by Segment - Percentage Breakdown of Value Sales for Monitoring and Diagnostic Devices and Insulin Delivery Devices for the Years 2012, 2020 & 2027

JAPAN
  • TABLE 16: Japan Current & Future Analysis for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 17: Japan Historic Review for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 18: Japan 15-Year Perspective for Diabetes Devices by Segment - Percentage Breakdown of Value Sales for Monitoring and Diagnostic Devices and Insulin Delivery Devices for the Years 2012, 2020 & 2027

CHINA
  • TABLE 19: China Current & Future Analysis for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 20: China Historic Review for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 21: China 15-Year Perspective for Diabetes Devices by Segment - Percentage Breakdown of Value Sales for Monitoring and Diagnostic Devices and Insulin Delivery Devices for the Years 2012, 2020 & 2027

EUROPE
  • Market Facts & Figures
  • European Diabetes Devices Market: Competitor Market Share Scenario (in %) for 2019 & 2025
  • Market Analytics
  • TABLE 22: Europe Current & Future Analysis for Diabetes Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
  • TABLE 23: Europe Historic Review for Diabetes Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 24: Europe 15-Year Perspective for Diabetes Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
  • TABLE 25: Europe Current & Future Analysis for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 26: Europe Historic Review for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 27: Europe 15-Year Perspective for Diabetes Devices by Segment - Percentage Breakdown of Value Sales for Monitoring and Diagnostic Devices and Insulin Delivery Devices for the Years 2012, 2020 & 2027

FRANCE
  • TABLE 28: France Current & Future Analysis for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 29: France Historic Review for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 30: France 15-Year Perspective for Diabetes Devices by Segment - Percentage Breakdown of Value Sales for Monitoring and Diagnostic Devices and Insulin Delivery Devices for the Years 2012, 2020 & 2027

GERMANY
  • TABLE 31: Germany Current & Future Analysis for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 32: Germany Historic Review for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 33: Germany 15-Year Perspective for Diabetes Devices by Segment - Percentage Breakdown of Value Sales for Monitoring and Diagnostic Devices and Insulin Delivery Devices for the Years 2012, 2020 & 2027

ITALY
  • TABLE 34: Italy Current & Future Analysis for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 35: Italy Historic Review for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 36: Italy 15-Year Perspective for Diabetes Devices by Segment - Percentage Breakdown of Value Sales for Monitoring and Diagnostic Devices and Insulin Delivery Devices for the Years 2012, 2020 & 2027

UNITED KINGDOM
  • TABLE 37: UK Current & Future Analysis for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 38: UK Historic Review for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 39: UK 15-Year Perspective for Diabetes Devices by Segment - Percentage Breakdown of Value Sales for Monitoring and Diagnostic Devices and Insulin Delivery Devices for the Years 2012, 2020 & 2027

SPAIN
  • TABLE 40: Spain Current & Future Analysis for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 41: Spain Historic Review for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 42: Spain 15-Year Perspective for Diabetes Devices by Segment - Percentage Breakdown of Value Sales for Monitoring and Diagnostic Devices and Insulin Delivery Devices for the Years 2012, 2020 & 2027

RUSSIA
  • TABLE 43: Russia Current & Future Analysis for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 44: Russia Historic Review for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 45: Russia 15-Year Perspective for Diabetes Devices by Segment - Percentage Breakdown of Value Sales for Monitoring and Diagnostic Devices and Insulin Delivery Devices for the Years 2012, 2020 & 2027

REST OF EUROPE
  • TABLE 46: Rest of Europe Current & Future Analysis for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 47: Rest of Europe Historic Review for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 48: Rest of Europe 15-Year Perspective for Diabetes Devices by Segment - Percentage Breakdown of Value Sales for Monitoring and Diagnostic Devices and Insulin Delivery Devices for the Years 2012, 2020 & 2027

ASIA-PACIFIC
  • TABLE 49: Asia-Pacific Current & Future Analysis for Diabetes Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
  • TABLE 50: Asia-Pacific Historic Review for Diabetes Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 51: Asia-Pacific 15-Year Perspective for Diabetes Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
  • TABLE 52: Asia-Pacific Current & Future Analysis for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 53: Asia-Pacific Historic Review for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 54: Asia-Pacific 15-Year Perspective for Diabetes Devices by Segment - Percentage Breakdown of Value Sales for Monitoring and Diagnostic Devices and Insulin Delivery Devices for the Years 2012, 2020 & 2027

AUSTRALIA
  • TABLE 55: Australia Current & Future Analysis for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 56: Australia Historic Review for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 57: Australia 15-Year Perspective for Diabetes Devices by Segment - Percentage Breakdown of Value Sales for Monitoring and Diagnostic Devices and Insulin Delivery Devices for the Years 2012, 2020 & 2027

INDIA
  • TABLE 58: India Current & Future Analysis for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 59: India Historic Review for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 60: India 15-Year Perspective for Diabetes Devices by Segment - Percentage Breakdown of Value Sales for Monitoring and Diagnostic Devices and Insulin Delivery Devices for the Years 2012, 2020 & 2027

SOUTH KOREA
  • TABLE 61: South Korea Current & Future Analysis for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 62: South Korea Historic Review for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 63: South Korea 15-Year Perspective for Diabetes Devices by Segment - Percentage Breakdown of Value Sales for Monitoring and Diagnostic Devices and Insulin Delivery Devices for the Years 2012, 2020 & 2027

REST OF ASIA-PACIFIC
  • TABLE 64: Rest of Asia-Pacific Current & Future Analysis for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 65: Rest of Asia-Pacific Historic Review for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 66: Rest of Asia-Pacific 15-Year Perspective for Diabetes Devices by Segment - Percentage Breakdown of Value Sales for Monitoring and Diagnostic Devices and Insulin Delivery Devices for the Years 2012, 2020 & 2027

LATIN AMERICA
  • TABLE 67: Latin America Current & Future Analysis for Diabetes Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
  • TABLE 68: Latin America Historic Review for Diabetes Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 69: Latin America 15-Year Perspective for Diabetes Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
  • TABLE 70: Latin America Current & Future Analysis for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 71: Latin America Historic Review for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 72: Latin America 15-Year Perspective for Diabetes Devices by Segment - Percentage Breakdown of Value Sales for Monitoring and Diagnostic Devices and Insulin Delivery Devices for the Years 2012, 2020 & 2027

ARGENTINA
  • TABLE 73: Argentina Current & Future Analysis for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 74: Argentina Historic Review for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 75: Argentina 15-Year Perspective for Diabetes Devices by Segment - Percentage Breakdown of Value Sales for Monitoring and Diagnostic Devices and Insulin Delivery Devices for the Years 2012, 2020 & 2027

BRAZIL
  • TABLE 76: Brazil Current & Future Analysis for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 77: Brazil Historic Review for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 78: Brazil 15-Year Perspective for Diabetes Devices by Segment - Percentage Breakdown of Value Sales for Monitoring and Diagnostic Devices and Insulin Delivery Devices for the Years 2012, 2020 & 2027

MEXICO
  • TABLE 79: Mexico Current & Future Analysis for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 80: Mexico Historic Review for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 81: Mexico 15-Year Perspective for Diabetes Devices by Segment - Percentage Breakdown of Value Sales for Monitoring and Diagnostic Devices and Insulin Delivery Devices for the Years 2012, 2020 & 2027

REST OF LATIN AMERICA
  • TABLE 82: Rest of Latin America Current & Future Analysis for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 83: Rest of Latin America Historic Review for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 84: Rest of Latin America 15-Year Perspective for Diabetes Devices by Segment - Percentage Breakdown of Value Sales for Monitoring and Diagnostic Devices and Insulin Delivery Devices for the Years 2012, 2020 & 2027

MIDDLE EAST
  • TABLE 85: Middle East Current & Future Analysis for Diabetes Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
  • TABLE 86: Middle East Historic Review for Diabetes Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 87: Middle East 15-Year Perspective for Diabetes Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
  • TABLE 88: Middle East Current & Future Analysis for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 89: Middle East Historic Review for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 90: Middle East 15-Year Perspective for Diabetes Devices by Segment - Percentage Breakdown of Value Sales for Monitoring and Diagnostic Devices and Insulin Delivery Devices for the Years 2012, 2020 & 2027

IRAN
  • TABLE 91: Iran Current & Future Analysis for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 92: Iran Historic Review for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 93: Iran 15-Year Perspective for Diabetes Devices by Segment - Percentage Breakdown of Value Sales for Monitoring and Diagnostic Devices and Insulin Delivery Devices for the Years 2012, 2020 & 2027

ISRAEL
  • TABLE 94: Israel Current & Future Analysis for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 95: Israel Historic Review for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 96: Israel 15-Year Perspective for Diabetes Devices by Segment - Percentage Breakdown of Value Sales for Monitoring and Diagnostic Devices and Insulin Delivery Devices for the Years 2012, 2020 & 2027

SAUDI ARABIA
  • TABLE 97: Saudi Arabia Current & Future Analysis for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 98: Saudi Arabia Historic Review for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 99: Saudi Arabia 15-Year Perspective for Diabetes Devices by Segment - Percentage Breakdown of Value Sales for Monitoring and Diagnostic Devices and Insulin Delivery Devices for the Years 2012, 2020 & 2027

UNITED ARAB EMIRATES
  • TABLE 100: UAE Current & Future Analysis for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 101: UAE Historic Review for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 102: UAE 15-Year Perspective for Diabetes Devices by Segment - Percentage Breakdown of Value Sales for Monitoring and Diagnostic Devices and Insulin Delivery Devices for the Years 2012, 2020 & 2027

REST OF MIDDLE EAST
  • TABLE 103: Rest of Middle East Current & Future Analysis for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 104: Rest of Middle East Historic Review for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 105: Rest of Middle East 15-Year Perspective for Diabetes Devices by Segment - Percentage Breakdown of Value Sales for Monitoring and Diagnostic Devices and Insulin Delivery Devices for the Years 2012, 2020 & 2027

AFRICA
  • TABLE 106: Africa Current & Future Analysis for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
  • TABLE 107: Africa Historic Review for Diabetes Devices by Segment - Monitoring and Diagnostic Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • TABLE 108: Africa 15-Year Perspective for Diabetes Devices by Segment - Percentage Breakdown of Value Sales for Monitoring and Diagnostic Devices and Insulin Delivery Devices for the Years 2012, 2020 & 2027

IV. COMPETITION
  • Total Companies Profiled: 42